Tag: psoriatic arthritis treatment market forecast

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Are the Primary Drivers Supporting the Market Growth of thePsoriatic Arthritis Treatment Market?

The psoriatic arthritis treatment market is growing due to the rise in psoriasis and psoriatic arthritis cases. Psoriasis, associated with psoriatic arthritis (PsA), has a significant incidence among patients. For example, a National Library of Medicine report indicates that the likelihood of developing PsA increases significantly with time after a psoriasis diagnosis. This growing prevalence is fueling the demand for PsA treatments.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3458&type=smp

#How Will the CAGR of the Psoriatic Arthritis Treatment Market Influence Its Overall Growth by 2034?

The psoriatic arthritis treatment market size has grown strongly in recent years. It will grow from $10.93 billion in 2024 to $12 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth is due to increased diagnosis rates, rising prevalence of psoriatic arthritis, greater awareness of treatments, and the expanding range of approved therapies, supported by government and pharmaceutical company investments.

The psoriatic arthritis treatment market is set for strong growth, reaching $17.16 billion by 2029 at a CAGR of 9.4%. Growth is driven by personalized medicine, emerging biologics and small molecules, expanding treatment options, and a growing aging population. Major trends include advances in biologics, oral small molecules, targeted therapies, telemedicine and remote monitoring, patient-centered care, and real-world evidence.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3458

What Are the Most Significant Market Trends Transforming thePsoriatic Arthritis Treatment Market?

In the psoriatic arthritis treatment market, companies are focusing on advanced products like targeted biologic therapies to offer more personalized treatments. For example, AbbVie’s SKYRIZI (risankizumab-rzaa), approved in January 2022, is an interleukin-23 inhibitor designed to target inflammation at its source, showing significant improvements in joint symptoms and overall disease activity.

Who Are the Major Industry Players Accelerating Growth in thePsoriatic Arthritis Treatment Market?

Major companies operating in the psoriatic arthritis treatment market include AbbVie Inc., Amgen Astellas BioPharma K.K., Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Celgene Corporation, Novartis International AG, Eli Lilly and Company, Pfizer Inc., CB Biosciences Inc., Merck & Co. Inc., AstraZeneca plc, Sanofi SA, Otsuka Pharmaceutical Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Bayer AG, Abbott Laboratories, Eisai Inc., Janssen Pharmaceuticals Inc., Bausch Health Companies Inc., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline plc, LEO Pharma A/S, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International Inc., Chugai Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd.

https://www.thebusinessresearchcompany.com/report/psoriatic-arthritis-treatments-global-market-report

Which Primary Segments of the Psoriatic Arthritis Treatment Market Are Driving Growth and Industry Transformations?

The psoriatic arthritis treatment market covered in this report is segmented –

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDS), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biologics, Other Drug Classes

2) By Route Of Administration: Oral, Parenteral, Topical

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Traditional NSAIDs, COX-2 Inhibitors

2) By Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Conventional DMARDs, Targeted Synthetic DMARDs

3) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Other Biologics

4) By Other Drug Classes: Corticosteroids, Topical Treatments, Janus Kinase (JAK) Inhibitors

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=3458&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of thePsoriatic Arthritis Treatment Market?# Market?

The countries covered in the psoriatic arthritis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Browse Through More Reports Similar to the Global Psoriatic Arthritis Treatment Market 2025, By The Business Research Company:

Hydroxychloroquine Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hydroxychloroquines-global-market-report

Arthritis Monoclonal Antibodies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/arthritis-monoclonal-antibodie-global-market-report

Musculoskeletal Disorders Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/musculoskeletal-disorder-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the psoriatic arthritis treatment market?

The market for psoriatic arthritis treatments has been flourishing in the past few years. Its size is expected to surge from $10.93 billion in 2024 to $12 billion in 2025, boasting a compound annual growth rate (CAGR) of 9.8%. Contributing factors to the past growth include better diagnosis processes, growing instances of psoriatic arthritis, heightened awareness about the condition and its available treatments, a broadening selection of approved interventions for psoriatic arthritis, governmental backing for research and development initiatives, and amplified investments from the pharmaceutical industry.

What will be the psoriatic arthritis treatment market size in the future?

The market size for treatment of psoriatic arthritis is predicted to undergo substantial expansion in the upcoming years, reaching $17.16 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 9.4%. The growth projected for the forecast period is associated with factors such as personalized medicine, the advent of biologics and small molecules, and an ever-increasing array of treatment options along with the worldwide aging populace. Key trends to note for the forecast period include the progression in biologics, oral small molecules, targeting of specific pathways, telemedicine and monitoring from remote locations, patient-focused care, and empirical evidence from real-world experience.

Get your psoriatic arthritis treatment market report here!

https://www.thebusinessresearchcompany.com/sample.aspx?id=3458&type=smp

What main drivers are fueling expansion in the psoriatic arthritis treatment market?

The growth of the market for psoriatic arthritis treatment is spurred by an increase in the occurrence of psoriasis and psoriatic arthritis. Both psoriasis (PSO) and psoriatic arthritis (PsA) are inflammatory disorders that can greatly affect a person’s health and quality of life. Psoriasis is linked to inflammatory arthritis, also known as psoriatic arthritis (PsA), occurring in about 30% of patients with psoriasis. As an example, the National Library of Medicine, a US-based government entity, published reports in January 2024 stating that the annual incidence of psoriatic arthritis in patients with psoriasis falls between 1.9% to 2.7% per 100 patients. The probability of developing PsA rises considerably over time, with rates of 1.7% at 5 years, 3.1% at 10 years, and soaring to 20.5% at 30 years after a diagnosis of psoriasis. As such, an increase in the prevalence of psoriasis and psoriatic arthritis is driving the growth of this market.

What key areas define the segmentation of the global psoriatic arthritis treatment market?

The psoriatic arthritis treatment market covered in this report is segmented –

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDS), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biologics, Other Drug Classes

2) By Route Of Administration: Oral, Parenteral, Topical

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Traditional NSAIDs, COX-2 Inhibitors

2) By Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Conventional DMARDs, Targeted Synthetic DMARDs

3) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Other Biologics

4) By Other Drug Classes: Corticosteroids, Topical Treatments, Janus Kinase (JAK) Inhibitors

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3458&type=smp

Who are the dominant players expanding their reach in the psoriatic arthritis treatment market?

Major companies operating in the psoriatic arthritis treatment market include AbbVie Inc., Amgen Astellas BioPharma K.K., Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Celgene Corporation, Novartis International AG, Eli Lilly and Company, Pfizer Inc., CB Biosciences Inc., Merck & Co. Inc., AstraZeneca plc, Sanofi SA, Otsuka Pharmaceutical Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Bayer AG, Abbott Laboratories, Eisai Inc., Janssen Pharmaceuticals Inc., Bausch Health Companies Inc., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline plc, LEO Pharma A/S, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International Inc., Chugai Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd.

How are evolving market trends shaping psoriatic arthritis treatment Strategies?

Key players in the psoriatic arthritis treatment market are channeling their efforts towards the creation of innovative products such as targeted biologic therapy. The aim is to provide personalized and more impactful treatment solutions that tackle the core inflammatory processes, boost patient outcomes, and improve the quality of life for those affected by this persistent disease. Targeted biologic therapy is a treatment that harnesses strategically fashioned drugs or substances to interfere with specific molecules that spark the growth and dissemination of cancer cells. Its main goal is to lessen harm to healthy cells while optimizing therapeutic results. For instance, in January 2022, a biopharmaceutical firm located in the U.S known as AbbVie, which is involved in the discovery and development of medications, declared that the U.S. Food and Drug Administration (FDA) approved SKYRIZI (risankizumab-rzaa). SKYRIZI® (risankizumab-rzaa) is an inhibitor of interleukin-23. It is chiefly employed to treat active psoriatic arthritis by curbing inflammation at its roots through blocking the p19 subunit of IL-23. Clinical trials have exhibited significant advancements in joint symptoms and overall disease activity, with a large number of patients achieving clinical remission and an improved quality of life. This treatment option, provided via subcutaneous injection, offers convenience to patients and permits the modulation of dosing schedules to meet specific patient needs.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3458

Which regions are emerging as leaders in the psoriatic arthritis treatment market?

North America was the largest region in the psoriatic arthritis treatment market in 2024. The regions covered in the psoriatic arthritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Browse Through More Similar Reports By The Business Research Company:

Hydroxychloroquine Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hydroxychloroquines-global-market-report

Arthritis Monoclonal Antibodies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/arthritis-monoclonal-antibodie-global-market-report

Musculoskeletal Disorders Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/musculoskeletal-disorder-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Factors Are Driving the Anticipated Growth Rate of the Psoriatic Arthritis Treatment Market Through 2034?

The market for psoriatic arthritis treatments has been flourishing in the past few years. Its size is expected to surge from $10.93 billion in 2024 to $12 billion in 2025, boasting a compound annual growth rate (CAGR) of 9.8%. Contributing factors to the past growth include better diagnosis processes, growing instances of psoriatic arthritis, heightened awareness about the condition and its available treatments, a broadening selection of approved interventions for psoriatic arthritis, governmental backing for research and development initiatives, and amplified investments from the pharmaceutical industry.

The market size for treatment of psoriatic arthritis is predicted to undergo substantial expansion in the upcoming years, reaching $17.16 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 9.4%. The growth projected for the forecast period is associated with factors such as personalized medicine, the advent of biologics and small molecules, and an ever-increasing array of treatment options along with the worldwide aging populace. Key trends to note for the forecast period include the progression in biologics, oral small molecules, targeting of specific pathways, telemedicine and monitoring from remote locations, patient-focused care, and empirical evidence from real-world experience.

What Major Innovations Are Driving the Accelerated Growth of the Psoriatic Arthritis Treatment Market?

The growth of the market for psoriatic arthritis treatment is spurred by an increase in the occurrence of psoriasis and psoriatic arthritis. Both psoriasis (PSO) and psoriatic arthritis (PsA) are inflammatory disorders that can greatly affect a person’s health and quality of life. Psoriasis is linked to inflammatory arthritis, also known as psoriatic arthritis (PsA), occurring in about 30% of patients with psoriasis. As an example, the National Library of Medicine, a US-based government entity, published reports in January 2024 stating that the annual incidence of psoriatic arthritis in patients with psoriasis falls between 1.9% to 2.7% per 100 patients. The probability of developing PsA rises considerably over time, with rates of 1.7% at 5 years, 3.1% at 10 years, and soaring to 20.5% at 30 years after a diagnosis of psoriasis. As such, an increase in the prevalence of psoriasis and psoriatic arthritis is driving the growth of this market.

Get Your Free Sample of the Global Psoriatic Arthritis Treatment Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=3458&type=smp

Who Are the Major Industry Leaders Accelerating Growth in the Psoriatic Arthritis Treatment Market?

Major companies operating in the psoriatic arthritis treatment market include AbbVie Inc., Amgen Astellas BioPharma K.K., Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Celgene Corporation, Novartis International AG, Eli Lilly and Company, Pfizer Inc., CB Biosciences Inc., Merck & Co. Inc., AstraZeneca plc, Sanofi SA, Otsuka Pharmaceutical Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Bayer AG, Abbott Laboratories, Eisai Inc., Janssen Pharmaceuticals Inc., Bausch Health Companies Inc., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline plc, LEO Pharma A/S, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International Inc., Chugai Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd.

Which Upcoming Trends Are Set to Influence the Psoriatic Arthritis Treatment Market’s Path Forward?

Key players in the psoriatic arthritis treatment market are channeling their efforts towards the creation of innovative products such as targeted biologic therapy. The aim is to provide personalized and more impactful treatment solutions that tackle the core inflammatory processes, boost patient outcomes, and improve the quality of life for those affected by this persistent disease. Targeted biologic therapy is a treatment that harnesses strategically fashioned drugs or substances to interfere with specific molecules that spark the growth and dissemination of cancer cells. Its main goal is to lessen harm to healthy cells while optimizing therapeutic results. For instance, in January 2022, a biopharmaceutical firm located in the U.S known as AbbVie, which is involved in the discovery and development of medications, declared that the U.S. Food and Drug Administration (FDA) approved SKYRIZI (risankizumab-rzaa). SKYRIZI® (risankizumab-rzaa) is an inhibitor of interleukin-23. It is chiefly employed to treat active psoriatic arthritis by curbing inflammation at its roots through blocking the p19 subunit of IL-23. Clinical trials have exhibited significant advancements in joint symptoms and overall disease activity, with a large number of patients achieving clinical remission and an improved quality of life. This treatment option, provided via subcutaneous injection, offers convenience to patients and permits the modulation of dosing schedules to meet specific patient needs.

Get Instant Access to the Global Psoriatic Arthritis Treatment Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/psoriatic-arthritis-treatments-global-market-report

How Are the Key Segments of the Psoriatic Arthritis Treatment Market Driving Opportunities and Innovations?

The psoriatic arthritis treatment market covered in this report is segmented –

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDS), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biologics, Other Drug Classes

2) By Route Of Administration: Oral, Parenteral, Topical

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Traditional NSAIDs, COX-2 Inhibitors

2) By Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Conventional DMARDs, Targeted Synthetic DMARDs

3) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Other Biologics

4) By Other Drug Classes: Corticosteroids, Topical Treatments, Janus Kinase (JAK) Inhibitors

Which Regions Are Key Players in the Growth of the Psoriatic Arthritis Treatment Market?

The countries covered in the psoriatic arthritis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Key Elements Shape the Definition of the Psoriatic Arthritis Treatment Market?

Psoriatic arthritis treatment refers to a method of treatment or drug used to stop or lessen a chronic inflammatory disease of the joints and the areas where tendons and ligaments attach to the bones (entheses). This treatment focuses on controlling skin involvement and treating joint pain and disability.

Browse Through More Similar Reports By The Business Research Company:

Hydroxychloroquine Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hydroxychloroquines-global-market-report

Arthritis Monoclonal Antibodies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/arthritis-monoclonal-antibodie-global-market-report

Musculoskeletal Disorders Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/musculoskeletal-disorder-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: